Chronic cough can have a debilitating effect on a patient's life. Read our latest article exploring the emotions in patients affected by chronic cough. journals.sagepub.com/doi/10.1177/17…

Excited to be at #ERSCongress today! Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine

📍#ERSCongress Check out this fascinating abstract: “Mepolizumab induces proteome changes in eosinophils from severe eosinophilic asthma” - coauthored by our editorial board member Francisco-Javier Gonzalez-Barcala. #ERS2025 #Asthma

Great turnout at ALERT 1: Obstructive Airway Diseases in Children and Adults, with our Associate Editor Prof Antonio Spanevello contributing as a discussant. Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress

Enjoyed the session on Emerging Clinical Trials in Pulmonary Fibrosis, co-chaired by our Editor-in-Chief Dr. Nazia Chaudhuri. A popular and timely discussion with lots of interest from attendees. #ERS2025 #ERSCongress2025 #ClinicalTrials

📢About to begin: ALERT 2 – Infections, Lung Cancer and Respiratory Symptoms Management Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights🫁 #ERSCongress2025

It's our second day at #ERS2025! Today’s programme includes sessions chaired by our Associate Editors and Editor-in-Chief. Looking forward to the discussions ahead. #ERSCongress

📣Just published: a plain language summary of publication exploring how doctors and patients communicate about treatment for systemic sclerosis-associated interstitial lung disease. 👉Read it here: journals.sagepub.com/doi/full/10.11… #SSc #ILD

🔥 Lungs on Fire: Interstitial Lung Diseases is now live at #ERS2025 - a packed session co-chaired by our Editor-in-Chief, Dr Nazia Chaudhuri. #ERSCongress

Great to connect with Editor-in-Chief ILD IPF Doc: Nazia Chaudhuri and several Associate Editors of Therapeutic Advances in Respiratory Disease at #ERSCongress2025 yesterday. Valuable discussions around editorial priorities and future plans! #ERS2025 #RespiratoryDisease

At #ERS2025, Associate Editor Dr Shaney Barratt chaired a poster session on Clinical prognostication in pulmonary fibrosis. The session highlighted current approaches and future directions in predicting disease progression. #ERSCongress2025 #PulmonaryFibrosis

Associate Editor Corrado Pelaia is chairing a session at #ERS2025: Remission/stability in airway diseases – how to achieve it and what’s next? Exploring strategies for long-term disease control and emerging research. #ERSCongress2025 #AirwayDiseases

Lungs on fire 🔥 - the ERS session on respiratory infections is about to kick off. Looking forward to insights from Associate Editor Tom Wilkinson, who's joining as a discussant. #ERSCongress2025 #ERS2025 #RespiratoryHealth

If you have COPD, you may experience self-blame, guilt and shame because of the persisting stigma associated with COPD. People with COPD deserve to live freely without stigma or guilt, and to have a good quality of life. Share the COPD Patient Charter: copdcanada.info/copd-patient-c…

📢 Call for nominations! 📢 Do you know someone in the PR field who should be highlighted for their work? Whether early, mid, or lifetime career award applies, or just recognition for outstanding service, spotlight those in the field. Nominations are open now through Dec 31st!

Interstitial Lung Disease with Progressive fibrosis is associated with a worse prognosis. The latest study published in our journal outlines clinical predictors for long term survival in these patients to help identify higher risk groups! journals.sagepub.com/doi/10.1177/17…

1/2 Happening this week 🤩 ATS PR Journal Club: 30 Years of Skeletal Muscle Adaptation in COPD with François Maltais, MD   Date/Time: 12 p.m. ET, Thursday, Oct. 16 Assembly: Dr. François Maltais will join as VIP guest, with expert insights from Richard Casaburi & Martijn Spruit

The complexity of managing a patient with CTD-PAH can be dizzying. 😵‍💫 Our latest paper breaks down the management of these patients into practical pieces. journals.sagepub.com/doi/10.1177/17…

Mark your calendar for December 6th and join us in Charleston for the final A1F Education Day of the year! Hear from experts, connect with others, and gain valuable insights into Alpha-1 research and care. Register today: alpha1.org/event/2025-cha…

journals.sagepub.com/doi/10.1177/17… SMARCA4 deficient undifferentiated tumor is a rare cancer with high mortality. Read our latest case report about a patient who developed immune related cystitis after starting therapy.